Harmony Biosciences Holdings (HRMY) Return on Invested Capital (2022 - 2026)

Harmony Biosciences Holdings (HRMY) has 5 years of Return on Invested Capital data on file, last reported at 0.02% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.02%; the trailing twelve-month figure through Mar 2026 stood at 0.02% (changed 0.0% YoY), and the FY2025 full-year result was 0.11%, up 2.0% from the prior year.
• Return on Invested Capital fell to 0.02% in Q1 2026, from 0.03% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.26% in Q4 2022 to a low of 0.0% in Q1 2022.
• A 5-year average of 0.07% and a median of 0.03% in 2025 frame the typical range for Return on Invested Capital.
• Peak annual rise in Return on Invested Capital reached 20 bps in 2023, while the deepest fall reached 23 bps in 2023.
• Tracing HRMY's Return on Invested Capital over 5 years: stood at 0.26% in 2022, then plunged by 87 bps to 0.03% in 2023, then plunged by 31 bps to 0.02% in 2024, then gained by 10 bps to 0.03% in 2025, then dropped by 11 bps to 0.02% in 2026.
• Business Quant data shows HRMY's Return on Invested Capital at 0.02% in Q1 2026, 0.03% in Q4 2025, and 0.03% in Q3 2025.